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ABSTRACT39
The Hantaviridae family comprises mostly rodent-borne segmented negative sense40
RNA viruses, many of which are capable of causing devastating disease in humans. In41
contrast, hantavirus infection of rodent hosts results in a persistent and inapparent infection42
through their ability to evade immune detection and inhibit apoptosis. In this study, we used43
Tula hantavirus (TULV) to investigate the interplay between viral and host apoptotic responses44
during early, peak and persistent phases of virus infection in cell culture. Examination of early45
phase TULV infection revealed that infected cells were refractory to apoptosis evidenced by46
the complete lack of cleaved caspase-3 (casp-3C) staining, whereas in non-infected bystander47
cells casp-3C was highly abundant. Interestingly at later time points, casp-3C was abundant48
in infected cells, but cells remained viable and able to continue shedding infectious virus, and49
together these observations were suggestive of a TULV-associated apoptotic block. To50
investigate this block, we viewed TULV-infected cells using laser scanning confocal and wide-51
field deconvolution microscopy, which revealed TULV nucleocapsid protein (NP) colocalized52
with, and sequestered, casp-3C within cytoplasmic ultrastructures. Consistent with casp-3C53
colocalization, we showed for the first time that TULV NP was cleaved in cells and that TULV54
NP and casp-3C could be co-immunoprecipitated, suggesting this interaction was stable and55
thus unlikely solely confined to NP binding as a substrate to the casp-3C active site. To56
account for these findings, we propose a novel mechanism by which TULV NP inhibits57
apoptosis by spatially sequestering casp-3C from its downstream apoptotic targets within the58
cytosol.59
60
3INTRODUCTION61
The Orthohantavirus genus within the Hantaviridae family comprises many zoonotic62
segmented negative sense (SNS) RNA viruses that are capable of causing devastating human63
disease, often with fatal outcomes. Orthohantaviruses are broadly-spherical enveloped64
viruses, which possess a tripartite genome made up of small (S), medium (M) and large (L)65
RNA segments that minimally-encode the nucleocapsid protein (NP), glycoprotein precursor66
(GPC) and RNA dependent RNA polymerase (RdRp), respectively [1, 2]. Many members of67
the family also encode a small non-structural protein (NSs) accessed from an alternate open68
reading frame, and which acts as an antagonist of the innate immune response [3–5].69
Orthohantaviruses can be divided into New World (NW) and Old World (OW) clades70
based on their country of isolation, with OW viruses being widespread throughout Asia and71
Europe, and NW viruses found in the Americas [6]. Orthohantaviruses are typically associated72
with a specific rodent host, although recent evidence suggests that bats, shrews, moles and73
ray-finned fish also act as reservoirs [7, 8]. Orthohantaviruses have been shown to cause74
persistent, often apathogenic infections in these hosts, although there is some evidence to75
suggest infection is associated with reduced host survival [9–13] with histological examination76
of lungs, heart and livers of infected animals showing some signs of pathology [14].77
Orthohantaviruses are transmitted to humans by the inhalation of aerosolised excreta78
and other body fluids from the infected animal host, although direct human-to-human79
transmission has also been reported for Andes virus (ANDV) [15]. Several human pathologies80
have been observed for different orthohantavirus species, with the disease outcome closely81
correlating with the two orthohantavirus clades; OW orthohantaviruses are associated with82
haemorrhagic fever with renal syndrome (HFRS), whilst NW orthohantaviruses are the83
causative agent of hantavirus cardiopulmonary syndrome (HCPS). While these syndromes84
afflict different primary organs, both are characterised by excessive vascular leakage leading85
to shock, with human mortality rates ranging from 0.1-10% for HFRS and up to 40% for HCPS86
[16, 17]. Endothelial cells are the primary sites of hantavirus multiplication, although these87
cells do not display overt cytopathic effects [18]. This outcome is recapitulated in cell culture88
systems in which orthohantavirus infections are not associated with excessive cytopathology89
or cell lysis, and instead infections can become persistent with on-going virus shedding for up90
to 139 days post infection in the case of Seoul virus (SEOV) [19–21]. The ability of91
hantaviruses to persist suggests they are able to evade pathogen surveillance, and avoid92
innate immune defence mechanisms such as apoptosis.93
Apoptosis is an important component of cellular homeostasis. There are many94
apoptotic pathways, including the caspase cascade in which a series of cysteine-aspartate95
proteases are activated by cleavage [22]. Viruses have developed complex mechanisms to96
4modulate apoptotic signalling pathways to benefit their own survival, which can result in either97
delay or acceleration of apoptosis with pro-viral outcomes.98
There is considerable evidence to suggest that hantaviruses prevent the induction of99
apoptosis, consistent with their ability to establish persistence. Puumala virus (PUUV) NP has100
been shown to interact with the Fas-mediated apoptosis enhancer Daxx [23], whilst NP from101
Hantaan virus (HTNV) modulates apoptosis though down-regulating p53 [24]. Furthermore,102
a panel of six hantaviruses spanning three distinct serogroups (ANDV, Dobrava virus (DOBV),103
HTNV, PUUV, SEOV and Tula virus (TULV)) were each recently shown to supress apoptosis104
in staurosporine-treated cells. The same study suggested that NP plays a direct role in105
modulating apoptosis through the demonstration that NP can be cleaved by purified caspase-106
3. In addition, recombinant N protein from ANDV, DOBV and PUUV have been shown to inhibit107
both caspase-3 and granzyme B in cell free assays [25, 26].108
To better characterise the role of the hantavirus NP in modulating apoptosis, we used109
the model OW orthohantavirus TULV to examine how NP interacts with key components of110
the apoptotic machinery through an extended time course spanning early, peak, and a111
persistently-infected state. We demonstrate that TULV infection can persist for over 30 days112
in mammalian cells, with little or no apoptosis induction desite abundant levels of cleaved113
caspase 3 (casp-3C). We further show that TULV NP forms both punctate and tubular114
ultrastructures within intermediate and persistently-infected cells, in which active casp-3C is115
physically sequestered as a consequence of a robust and stable association with NP, leading116
to NP cleavage. We thus propose a model in which the ability of TULV to suppress apoptosis117
is driven by interactions between NP and casp-3C, leading to NP cleavage, and spatial118
separation of the executioner caspase from its downstream effectors.119
120
5METHODS121
Cell culture122
TULV Moravia strain 5302v/95 and Vero E6 cells were kindly provided by Dr Roger123
Hewson, Public Health England, UK. Virus propagation was carried out in Vero E6 cells grown124
in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% foetal bovine serum125
(FBS) (Sigma Aldrich), 100 U/mL penicillin and 100 µg/mL streptomycin at 37°C in a 5% CO2126
atmosphere. TULV stocks were confirmed as mycoplasma-free using MycoAlertTM (Lonza).127
128
Nucleocapsid protein production and purification129
A cDNA representing the NP open reading frame (ORF) from SEOV strain Humber130
(accession number JX879769.1) optimized for bacterial expression, was generated131
synthetically (GeneArt, Therrmo Fisher) and inserted in the pMK-RQ vector. This was132
subsequently used as the template for amplification of the NP ‘core’, comprising residues133
E111-G399 (NPcore) using the primer set 5’-TGTTGGATCCGAACCGACAG134
GTCAGACCGCAGATTG-3’ and 5’-GGTGCTCGAGTTAACCCAGGTGAAAGTTATCCACG135
GC-3’. The amplified core region was then cloned into the pET28a (+) expression vector136
behind sequences for both the 6xHis affinity tag, and the SUMO tag for over expression in137
Escherichia coli BL21 DE3 Gold cells. Bacterial cultures were induced using 0.5 mM IPTG138
and then incubated overnight at 18°C in a 180-rpm shaking incubator. Bacterial pellets were139
collected by centrifugation at 4,000 xg for 20 minutes at 4°C before resuspension in ice-cold140
lysis buffer (500 mM NaCl, 20 mM Tris-HCl pH 8, 20 mM MgCl2P0ȕPHUFDSWRHWKDQRO141
% Triton X-100, 1 mg/ml lysozyme (Sigma Aldrich), 1 pellet EDTA-free protease inhibitors142
(Roche), 1 U RNase, 1 U DNase) and sonicated. The insoluble fraction was pelleted by143
centrifugation at 20,000 xg for 1 hour at 4°C and soluble protein collected in the supernatant.144
The soluble fraction was then applied to a 5 ml HisTrapTM (GE Healthcare) column and washed145
with 5 column volumes of 25-100 mM imidazole wash buffers (500 mM NaCl, 20 mM Tris, 5146
P0 ȕ0H 5HFRPELQDQW 13core was eluted from the column using 10 column volumes of147
HOXWLRQEXIIHUP0LPLGD]ROHP01D&OP07ULVP0ȕPHUFDSWRHWKDQRO7KH148
6xHis SUMO tag was removed by incubation with 1U/ml Ulp1 protease overnight at 4°C. The149
cleaved protein was diluted 1:10 in 20 mM elution buffer before being passed over a 5 ml150
HisTrapTM column to remove tag and protease. The collected flow-through was concentrated151
in a 10 kDa molecular weight cut-off concentrator (Amicon) to 0.5 mg/ml. Purity (>85%) of the152
resulting NPcore was determined by densitometry following SDS-PAGE and Coomassie153
staining.154
155
156
6Antibodies157
TULV NP antibody was generated in sheep with 4x 200 mg inoculations of recombinant158
purified NPcore (Alta Biosciences, UK). Serum was collected pre-inoculation and post-1, -2, -3,159
-4 inoculations. Serum was centrifuged at 4,000xg for 20 minutes at 4°C to remove debris160
before being stored at -20°C. Polyclonal antibodies against cleaved caspase-3, caspase-3161
and cleaved PARP were purchased from New England Biolabs and monoclonal antibodies162
against GAPDH were purchased from GeneTex.163
164
Quantitative reverse transcriptase-PCR165
Quantitative RT-PCR was carried out as previously described [27] with adaptations to166
the GoTaq® 1-Step RT-qPCR System Protocol (Promega). TULV S segment RNA was167
isolated from infected cell culture medium using viral RNA mini kit (Qiagen) and reverse168
transcribed using the primers 5’-GCCTCTAGAATGAGCCAACTCAAAGAAATACAAGAGG-3’169
and 5’-GCCCTCGAGTTAGATTTTTAGCGGTTCCTGGTTTG-3’. The S segment ORF was170
sub-cloned into pCDNA3.1 (+) T7 expression vector and used as template for transcription S171
segment RNA using the mMESSAGE mMACHINE T7 Transcription Kit (Thermo Fisher172
Scientific) and purified using the RNeasy mini kit (Qiagen). RNA purity was assessed using173
electrophoresis examination (Fig 2A) and concentration adjusted to 108, 106, 104 and 102174
genomic copies per quantitative RT-PCR (qRT-PCR) reaction (5 µl). Genomic copies of175
experimental samples were determined from the generated standard curve.176
177
Virus infections178
Vero E6 cells were seeded out at a density of 1x105 cells per well for a 12-well plate or179
1x106 cells per 25 cm2 flask. TULV was adsorbed to monolayers at MOI 1-0.1 in DMEM for 90180
minutes before DMEM supplemented with 2% FBS, 100 U/ml penicillin and 100 µg/ml181
streptomycin (2% DMEM) was added. Persistent TULV infections were carried out in 25 cm2182
flasks and infected cells were seeded onto coverslips 24 hours before fixation. Cells were fixed183
in 4% paraformaldehyde at 36 hours post infection (hpi), 7 days post infection (dpi) and 30 dpi184
to demonstrate early, peak and persistent infections.185
186
TULV time course187
Vero E6 cells were seeded out at a density of 6x105 cells per well of a 6-well plate and188
infected with TULV at a MOI 0.1. At each time point, cells were scraped into the cell culture189
medium and stored at -80°C. Cell cultures were clarified by centrifuging at 20,000 xg for 10190
minutes at 4°C. RNA extractions were carried out on clarified cell culture supernatant using191
viral RNA mini kit (Qiagen) and RNA quantified in duplicate using 1-step qRT-PCR. Infectious192
TULV was titrated in triplicate using an immunofluorescence assay.193
7194
Virus titration195
Vero E6 cells were seeded out at a density of 5x103 cells per well of a 96-well plate or196
at 6x105 cells per well of a 6-well plate and incubated at 37°C in 5 % CO2 incubator overnight.197
TULV was diluted 10-1 to 10-5 at a 1:10 dilution in DMEM. Diluted virus was adsorbed to cell198
monolayers alongside neat TULV in volumes of 100 µl (96-well) and 200 µl (6-well). TULV199
was adsorbed for 90 minutes at 37°C on a rocking platform. Following adsorption, 100 µl 2 %200
FBS DMEM was added to 96-well plate cells and incubated at 37°C for 72 hours in a 5 % CO2201
incubator. For 6-well plates, inoculum was removed and overlaid with 3 ml 2% agarose diluted202
1:1 in 2% FBS DMEM was added to each well and incubated at 37°C for 7 days in a 5 % CO2203
incubator. A second overlay of 2 ml 2% agarose diluted 1:1 in 2 % FBS DMEM was added204
containing 45.3 µg/ml neutral red (Sigma Aldrich) before incubating at 37°C in a 5 % CO2205
incubator for a further 3 days. Plaques were considered areas with reduced staining and206
counted [28]. 96-well plate cells were fixed in ice-cold methanol and infected cells were207
identified through indirect staining using the anti-NPcore antibody in conjunction with an Alexa208
Fluor 488 secondary antibody (Thermo Fisher Scientific). The Incucyte Zoom instrument209
(Essen Bioscience) using a 10x objective lens was used to image infected monolayers. The210
Incucyte ZOOM software was used to calculate the number of infected cells per well by211
extrapolating an average a value from three fluorescent images of each well. Infectivity was212
quantified as immunofluorescent units per ml (IU/ml), which represented the number of213
resulting infectious foci per ml of inoculum. Each sample was quantified in triplicate.214
215
Indirect immunofluorescence216
Infected monolayers on coverslips were permeabilised in ice-cold methanol and217
incubated at -20°C for at least one hour before being washed in 1x PBS and blocked in 5 %218
BSA in 1x PBS (produced in-house). Primary antibody staining was carried out in 1% BSA in219
1x PBS using sheep anti-NPcore at 1:2,000 dilution and rabbit anti-cleaved caspase-3 (casp-220
3C) antibody at 1:200 dilution. Incubations were carried out for 2 hours at room temperature,221
then washed thoroughly in 1x PBS. Secondary antibody staining was carried out using Donkey222
anti-sheep Alexa Fluor 488 and Donkey anti-rabbit Alexa Fluor 647 at a 1:1,000 dilution for 1223
hour. DAPI staining was carried out by incubating with 300 mM DAPI 5 minutes at room224
temperature. Coverslips were mounted onto slides using VECTASHIELD Antifade Mounting225
Medium (Vector laboratories) and sealed using clear nail polish. Infected cells were imaged226
using the Zeiss LSM880 Upright confocal microscope at 40x magnification (Carl Zeiss Ltd)227
and the DeltaVision Widefield Deconvolution microscope at 100x magnification (GE228
Healthcare).229
230
8Western blotting231
TULV infections, as described above, were carried out on Vero E6 monolayers in 6-232
well plates. At 24, 48, 72, 96, 120, 144, 168, 192, 216 and 240 hpi cells were scraped into cell233
culture medium and collected by centrifugation at 20,000xg for 10 minutes at 4°C before234
resuspension in 50µl PBS. An equal volume of NuPage loading buffer (Thermo Fisher) was235
added and samples were heated at 95°C for 5 minutes. Protein samples were separated by236
15% SDS-PAGE and then transferred to an Immobilon-FL Polyvinylidene difluoride (PVDF)237
Membrane (Merck Millipore), which was probed with sheep anti-NPcore, rabbit anti-cleaved238
caspase 3 (casp-3C), caspase 3 (casp 3) and cleaved PARP (PARP-C). Mouse anti-GAPDH239
antibody was used as a loading control. Protein was detected using IRDye® 800CW Donkey240
anti-Goat IgG (H + L), IRDye® 800CW Donkey anti-Rabbit IgG (H + L) and IRDye® 680RD241
Donkey anti-Mouse IgG (H + L) and visualised by the Odyssey Imaging system (LI-COR).242
Densitometry was carried out using Fiji software.243
244
Co-immunoprecipitation245
Three 175cm3 flasks of Vero E6 cells at 60% confluency were infected with TULV at a246
MOI of 0.1, as previously described. At 30 dpi cells were scraped into the cell culture medium247
and centrifuged at 4,000 xg for 10 minutes at 4°C. Supernatant was discarded and the cell248
pellet was washed in 1x PBS, followed by resuspension in ice-cold lysis buffer (150mM NaCl,249
50mM TrisHCl (pH 8.0) 1% NP-40 alternative, 0.1% sodium dodecyl sulphate, 1x EDTA free250
protease inhibitor tablets (Roche)) and incubated on ice for 30 minutes before clarified by251
centrifuging at 1,000 xg for 10 minutes. Clarified lysate was used for TULV NP252
immunoprecipitation with anti-NPcore using Dynabeads Protein G Immunoprecipitation Kit253
(Thermo Fisher Scientific) following the manufacturers instructions. 1x NuPAGE loading dye254
was added directly to beads and samples were heated at 95°C for 5 minutes. Samples were255
centrifuged at 10,000 xg to pellet beads and supernantant was added to SDS-PAGE gels.256
Mock samples were treated similarly to infected, but without addition of TULV.257
258
9RESULTS259
Generation of tools to quantify TULV components and infectivity. To characterise260
the progression of TULV infection in cells throughout an extended time course, we first261
developed tools to accurately quantify both TULV components and infectivity. For TULV262
protein detection, we generated NP antisera, and based on phylogenetic analysis of OW clade263
hantavirus NP amino acid sequences, we selected the SEOV NP to raise polyclonal antisera264
that would be broadly cross-reactive to multiple hantavirus NPs, including TULV. The SEOV265
NP core (residues 111-399; NPcore) was bacterially-expressed and purified (Fig 1a, left panel)266
and used for antibody production. The resulting antisera showed cross-reactivity against267
recombinant SEOV NPcore expressed in bacteria by western blot analysis (Fig 1a, right panel)268
and against TULV NP generated in TULV-infected cells at 6 days post-infection (dpi) assessed269
by both western blotting (Fig 1b) and immunofluorescence (Fig 1c). These results confirmed270
the high specificity of the antisera, as evidenced by absent background or non-specific staining271
in mock-infected cells. In agreement with previous studies, TULV NP was detected in272
perinuclear ultrastructures, and cytoplasmic puncta [20].273
Alongside the production of NP antisera, we also established a rapid PCR-based assay274
for the quantitative detection of TULV vRNA replication products, calibrated using a standard275
curve generated using in vitro transcribed TULV S segment vRNA at a range of276
concentrations. The purity of the vRNA was verified using electrophoresis (Fig 1d) and Rsq277
YDOXHV)LJH278
Finally, we developed assays to measure TULV infection kinetics and virus production.279
Conventional infectivity assays reliant on plaque formation are problematical due to the low280
cytopathology of hantaviruses, with hantavirus infectivity often measured by neutral red281
uptake, which is both time-consuming and inaccurate, taking 10 days to produce poorly-visible282
plaques (Fig 2a). To remedy this, we developed an immunofluorescence (IF) based assay that283
relies on TULV NP antisera for detection of infected cells (Fig 2b). This method was used to284
examine the infectivity of a TULV dilution series and infected cell numbers followed a linear285
FXUYHZLWKD5VTYDOXHV)LJF286
287
Quantification of TULV components and infectivity across a 30-day time course.288
We next examined TULV multiplication and infectious particle production in Vero E6 cells over289
an extended time course. Cells were infected at an MOI of 0.1 after which supernatants and290
cell lysates were collected at regular timepoints up to 10 days post infection (dpi), with291
infections carried out at both 32 and 37oC. Additional samples from cultures incubated at 37oC292
were also taken at 15, 20, 25 and 30 dpi.293
NP antisera was used to measure NP accumulation in cell lysates harvested from 37oC294
cultures by western blotting, which served as a marker for viral gene expression and virus295
10
growth. Amplification of intracellular NP was first detected at 1 dpi (Fig 3a; 24 hpi), indicating296
a significant lag prior to the onset of detectable gene expression, also reflecting the low MOI297
used. Following this, NP abundance increased until 3 dpi (Fig 3a; 72 hpi), at which time NP298
abundance reached a plateau that did not decline up to 10 dpi (Fig 3a; 240 hpi). NP abundance299
relative to GAPDH was calculated using densitometry and represented graphically alongside300
(Fig 3a).301
Concomitantly, we used qRT-PCR to quantify the abundance of viral S segment RNAs,302
harvested as virion-associated RNA within released virus particles in the supernatant. This303
revealed a complex pattern that comprised an initial lag phase up to 30 hpi where viral RNA304
levels showed no increase over input, indicating an initial lag in genome production and virus305
release. This was subsequently followed by an exponential phase of rapid genome production,306
and a plateau in RNA detection that extended to 10 dpi. This pattern of RNA detection was307
observed in TULV grown at both 32°C and 37°C (Fig 3b) and was consistent with the profile308
of NP detection shown above (Fig 3a). At later time points (15-30 dpi) genome abundance did309
not increase further and gradually declined until the final 30 dpi measurement, although the310
vRNA abundance remained at least 1 log higher than the initial input (Fig 3c).311
To confirm that the detected RNA levels were due to the release of infectious virus312
particles, and not the release of defective or fragmented RNAs, we also measured TULV313
infectivity in the supernatants (Fig 3d and e). The overall pattern of infectivity closely followed314
that of genome RNA abundance with the release of infectious virus remaining at a consistent315
level until the 30 dpi harvest, a hallmark of a persistent infection. Based on these observations,316
we defined 1.5, 7 and 30 dpi as the time points representing distinct early, peak and persistent317
phases of virus multiplication, respectively.318
IF analysis of TULV infected cultures using NP antisera at 1.5, 7 and 30 dpi time points319
correlated with the above metrics (Fig 3f). At 1.5 dpi, NP staining was punctate and320
perinuclear, whereas at 7 and 30 dpi, the staining pattern noticeably changed with NP forming321
tubular ultrastructures in addition to distinct puncta. There was little evidence of nuclear322
fragmentation in infected cells at any of these time points, suggestive of a lack of virus induced323
apoptosis, although multinucleate syncytia were observed in the 30 dpi cultures.324
325
TULV infection interferes with apoptotic induction in Vero E6 cells. The results326
thus far showed that cultures of TULV-infected Vero E6 cells can be maintained for up to 30327
dpi without major cytopathic effects. This suggests that TULV infection does not readily lead328
to cell death, correlating with previous work that demonstrated the ability of hantaviruses to329
subvert apoptotic induction. To further examine the apoptotic response of Vero E6 cells to330
TULV infection, infected cell lysates were collected every 24 hours up to 10 dpi, and again at331
11
30 dpi, and the levels of total caspase-3, cleaved caspase-3 (casp-3C), and cleaved poly332
(ADP-ribose) polymerase (PARP-C) assessed (Fig 4).333
Total caspase-3 was detected in TULV-infected cells with its abundance increasing at334
later time points due to cell proliferation, consistent with the increasing abundance of the335
GAPDH loading control. The activated derivative casp-3C, indicative of apoptosis induction,336
was detected in TULV cell lysates from 5-6 dpi, with its abundance increasing up to 10 and 30337
dpi. However, whilst this was suggestive of TULV induced apoptosis in infected cell cultures,338
a lack of PARP-C was evident at 6-10 dpi, and only moderate PARP-C cleavage was observed339
at 30 dpi. Furthermore, the high levels of casp-3C at 30 dpi were inconsistent with the apparent340
health of cells in these persistent cultures (Fig 3f). Taken together, these findings suggest that341
although the executioner casp-3C was present in its active form, it failed to trigger cell death342
in TULV infected cells, possibly due to the activity of a TULV component.343
344
TULV induces apoptosis in bystander cells. The results thus far suggested that the345
downstream activity of executioner casp-3C may be suppressed in TULV-infected cells. We346
therefore investigated the intracellular location of casp-3C in relation to TULV NP in individual347
cells, first at at 1.5 dpi, representative of early stages of infection.348
At 1.5 dpi, ~10% of cells were infected, as evidenced by characteristic punctate TULV349
NP staining, with numbers of infected cells correlating with the initial MOI of 0.1 (Fig 5a). In350
TULV-infected cells, NP staining was abundant, whilst minimal casp-3C was detected.351
Interestingly, casp-3C was abundant in uninfected bystander cells, with four such examples352
shown (Fig 5b), with casp-3C staining in a punctate distribution that extended throughout the353
cytoplasm suggesting apoptotic induction possibly through receiving indirect pathogen354
recognition signals from adjacent TULV-infected cells. We propose the likely fate of these cells355
is death. Casp-3C staining was detected in over 60% of bystander cells but only in 4% of356
TULV-infected cells (Fig 5c). Fluorescent line scan analysis (Fig 5b, right panel) quantified the357
expression of casp-3C in one such bystander cell, and revealed clear segregation from the358
TULV N stain in an adjacent infected cell (Fig 5d). These data suggest that during the early359
stages of virus infection, TULV is not a potent inducer of apoptosis, most likely through the360
ability of a TULV component to suppress apoptotic stimuli.361
362
TULV NP sequesters casp-3C at later stages of infection. At 7 dpi, the majority of363
cells were infected by TULV, as evidenced by the accumulation of NP that exhibited both364
punctate staining, in addition to the formation of large tubular perinuclear structures (Figs 3f365
and 6a). These TULV-infected cells exhibited casp-3C staining, but it was noticeable that the366
levels of staining in relation to that exhibited within non-infected bystander cells was low,367
consistent with the suppression of apoptosis by a TULV component. Interestingly,368
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quantification of TULV NP and casp-3C staining by fluorescent line scan analysis revealed369
colocalization in several instances between the two markers within both characteristic puncta370
and larger tubular structures (Fig 6a; zoomed merge panel and associated line scan, left),371
although in other areas, the two signals were separate.372
Examination of TULV persistently-infected cultures at 30 dpi revealed all cells to be373
TULV-infected, and exhibiting characteristic TULV NP staining within both discrete puncta and374
larger tubular structures. As at 7 dpi (Fig 6a), casp-3C was detected in these TULV-infected375
cells and fluorescent line scan analysis (Fig 6b, zoomed merge panel and associated line376
scan, left) revealed the colocalization of casp-3C with NP in both punctate and large tubular377
structures.378
At these peak and persistent time points (7 and 30 dpi), when casp-3C was detected379
in TULV-infected cells, a distinct lack of apoptosis within the cells was evident, with most cells380
apparently healthy and able to sustain virus production (Fig 3e). These observations were381
difficult to reconcile with the abundance of casp-3C observed in these cells, other than a382
scenario in which active casp-3C was prevented from cleaving downstream substrates in the383
caspase cascade, possibly through its interaction with TULV NP.384
385
Examination of TULV NP and casp-3C colocalization using widefield386
deconvolution microscopy. To further examine the colocalization of TULV NP and casp-3C387
in 30 dpi persistently-infected cells, infected cells were assessed by wide field deconvolution388
microscopy (WFDM) to enhance the detection sensitivity. As with confocal microscopy (Fig 6),389
WFDM also revealed that TULV-infected cells exhibited casp-3C staining within discrete390
cytoplasmic puncta (Fig 7a). While some areas of casp-3C staining were distinct from TULV391
NP, a high level of colocalization was observed, with the casp-3C staining appearing to be392
contained within that of TULV NP. Analysis of the spatial distribution of the two proteins using393
multiple fluorescent line scan analyses (Fig 7b; line scans below) confirmed and quantified the394
TULV NP and casp-3C colocalised signals, consistent with a scenario in which TULV NP395
compartmentalizes casp-3C. Quantification of TULV NP/casp-3C puncta abundance across396
early, peak and persistent TULV-cultures revealed an increased number of colocalized puncta397
through progression of the 30 day time course, with nearly 30% colocalization of the two398
proteins at 30 dpi (Fig 7b, histogram).399
In other areas of persistently infected cells, NP and casp-3C staining remained400
separate, quantified using multiple line scans (Fig 7c), with quantitation of colocalization in401
early, peak and persistent TULV-cultures represented as a histogram.402
403
TULV NP is cleaved in infected cells and robustly associates with casp-3C. For404
the orthohantavirus members ANDV, DOBV and PUUV, recombinant casp-3C has been405
13
shown to mediate cleavage of their respective purified NPs in cell free assays [26]. In the case406
of ANDV, casp-3C cleaves ANDV NP at the sequence DLID285, which conforms to the407
consensus DXXD motif for caspase-3 cleavage and generates a major NP fragment with408
molecular mass of approximately 35 kDa. With this knowledge combined with our observation409
that casp-3C and NP colocalize in TULV-infected cells, we next explored the possibility that410
TULV-NP acted as a cleavage substrate in infected cells.411
Analysis of the TULV NP sequence revealed the presence of an identical DLID motif412
that is found in the ANDV NP, which was previously shown to be recongised and cleaved by413
casp-3C in cell-free assays. Interestingly, whilst the DLID motif was present in NPs from ANDV414
and TULV, it was absent in HTNV, PHV and SEOV (Fig 8a). Cleavage of the TULV NP at this415
site was predicted to generate TULV NP fragments of ~32 kDa and ~16 kDa. To test whether416
cleavage at this site occurs during infection, we examined TULV-infected cell lysates for NP-417
derived cleavage products by western blotting using anti-NP antisera, which revealed the418
abundant presence of NP cleavage products precisely matching these predicted masses (NP419
32 kDa and NP 16 kDa, respectively; Fig 8b). The 16 kDa NP fragment was detected with high420
abundance at 3 dpi, which coincided with the initial detection of full-length NP, suggesting that421
NP cleavage occurs early during TULV infection. The fact that TULV NP possesses the same422
casp-3C target motif as ANDV, along with the consistent colocalization of TULV NP and casp-423
3C shown above, strongly implicates casp-3C as being responsible for the TULV NP cleavage424
we observed.425
To further examine the TULV NP and casp-3C interaction, we next perfomed co-426
immunoprecipitation analysis using TULV NP antisera to pull down TULV NP and its427
interacting partners from 30 dpi TULV-infected cells. Subsequent western blot analysis of428
eluted fractions revealed the presence of full-length NP, as well as cleaved NP 32 kDa and429
NP 16 kDa forms, along with abundant casp-3C (Fig 8c). These data are entirely consistent430
with the co-localization studies described above (Fig 7b) and show the TULV NP and casp-431
3C interaction is highly stable. The ability of NP to pulldown casp-3C with such abundance432
argues for a scenario in which the interaction involves residues that are not confined to the433
casp-3C active site, which alone would be expected to result in an extremely transient434
enzyme:substrate interaction, not amenable to immunoprecipitation.435
Taken together, we demonstrate for the first time that a hantaviral NP interacts with436
casp-3C in infected cells in a robust and stable manner, and we suggest the nature of this437
interaction results in physical sequenstration of casp-3C within NP compartments, and drives438
the suppression of the apoptotic response.439
440
DISCUSSION441
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Here, we investigated the interplay between TULV and apoptosis induction in Vero E6442
cells throughout an extended time course, spanning early, peak and persistent phases of443
infection. Previous work [23, 25, 26, 29] has shown that TULV and other hantaviruses inhibit444
apoptosis, and two observations made in our current study lend support to this proposal. First,445
while casp-3C was undetectable in TULV-infected cells at 1.5 dpi, in the same cultures, casp-446
3C was highly abundant in non-infected bystander cells, consistent with the ability of a TULV447
component to block apoptotic induction. Second, we showed that TULV can form persistently448
infected cultures up to 30 dpi without significant levels of CPE or the development of an449
apoptotic phenotype, despite casp-3C being highly abundant.450
Our finding that TULV hinders apoptotic induction is in agreement with published work,451
but is in conflict with some previous studies in which TULV-infection was associated with452
abundant detection of apoptotic markers by western blotting [30–32]. However, we propose453
that this discrepancy may have arisen through technical differences in the approaches used454
to detect apoptotic markers. Here, we examined the spatial distribution of both NP and455
apoptotic markers in individual cells, rather than culture lysates that comprise both infected456
and uninfected cells. Whilst fluorescent imaging revealed the abundant detection of casp-3C457
at early time points following infection, it was predominantly located in bystander cells, rather458
than in TULV-infected cells. Thus, we propose that apoptosis of bystander cells, rather than459
TULV-infected cells, may be the source of apoptotic markers observed in previous studies.460
Bystander effects have been described previously in SEOV, HTNV, ANDV, [31] and HIV where461
the Env glycoprotein induces apoptotic induction in neighbouring cells [33] and has been462
utilised in cancer therapy by the use of “suicide genes” which allow production of a toxic463
metabolite that acts deleteriously on neighbouring cells [34].464
Previous work has shown that a variety of hantaviral NPs, either expressed465
recombinantly, or purified from virions, can be cleaved in cell free assays by recombinant466
activated caspase 3. Here, we show that TULV NP is cleaved during infection (Fig 8a), with467
the apparent mass of released fragments being consistent with caspase-3 cleavage at a468
conserved DLID sequence, identical to that recently identified as a caspase-3 cleavage site469
for ANDV NP [26]. The role of TULV NP cleavage in these infected cells remains470
undetermined. One possibility is that it acts as a ‘decoy’ substrate, as was reported for Junin471
arenavirus (JUNV) [35] in which the JUNV NP delays the onset of apoptosis by acting as a472
‘caspase sink’, diverting caspase-3 from the cleavage of downstream effectors. An equivalent473
scenario for TULV NP is entirely consistent with our findings that TULV NP associates with474
casp-3C and is cleaved, as well as the established ability of TULV to delay the apoptotic475
response.476
However, we suggest that NP might delay or hinder the apoptotic response using a477
different mechanism. The ability of NP to interact with casp-3C, as determined by both indirect478
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immunofluorescent imaging and immunoprecipitation analysis revelas a highly robust479
interaction. Interestingly, line scans (Fig 7b) revealed that the TULV NP and casp-3C480
colocalizing signals were not precisely occupying the same positions, rather NP appeared to481
form a distinct boundary around casp-3C, suggestive of a virus-induced compartment in which482
casp-3C was physically separated from the cytosolic environment. The demonstration that483
casp-3C and NP could be immunoprecipitated by NP antisera is perhaps not surprising given484
the extensive immunofluorescent colocalization described above, however it reveals a robust485
and stable casp-3C/NP interaction, and one that differs from a canonical enzyme:substrate486
interaction that involves binding at the active site alone. The apparent stability of the TULV NP487
and casp-3C interaction, as demonstrated by their co-immunoprecipitation, argues that the488
interaction likely encompasses additional residues outside of the active site, and that the489
association of these two components is not transient.490
Based on this evidence, we propose a model in which TULV NP compartmentalizes491
casp-3C and physically separates it from downstream components of the caspase apoptotic492
cascasde. This mechanism of apoptosis protection has been previously demonstrated in other493
W\SHVRIKXPDQGLVHDVH,Q$O]KHLPHU¶VGLVHDVHDP\ORLGȕ$ȕILEULOVVHTXHVWHUFDVSDVH494
into compartments to protect cells from apoptosis [36]. Heat shock protein 27 (Hsp27) also495
sequesters procaspase-3 and cytochrome-c which prevents the formation of the apoptosome496
during thermotolerance [37]. In addition, the ced-9 molecule, a Bcl-2 homolog, found in497
Caenorhabditis elegans is a well-established example of a protein that regulates apoptosis by498
sequestering the caspase-activating factor ced-4, an analogue of mammalian Apaf-1, to the499
mitochondria, preventing non-programmed apoptosis. When the interaction between ced-9500
and ced-4 is disrupted, downstream caspase cleavage and it subsequent activation result in501
apoptosis [38–40]. These examples provide precedent for apoptotic protein sequestration502
acting to prevent apoptosis in both health and disease systems.503
In summary, the colocalization and co-precipitation of TULV NP and casp-3C, paired504
with the presence of a casp-3C recognition site provides evidence that NP is involved in505
interference of the host cell apoptotic pathway. We therefore suggest that TULV NP interferes506
with apoptosis by binding to and sequestering active caspase-3 in NP-coated compartments507
preventing casp-3C activation of its downstream substrates.508
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Figure legends
Figure 1. Identification and quantification of TULV components. a) Bacterially expressed
and purified recombinant SEOV NPcore used for antigen production migrated with an apparent
molecular weight of ~30 kDa following SDS-PAGE, as visualized by Coomassie staining. The
SEOV NPcore was detected using NPcore antisera by western blotting. b) Cross-reactivity of the
SEOV NPcore antisera against TULV NP (~50 kDa) expressed in infected Vero E6 cell lysates,
shown by western blotting. Cell lysates were collected at 120 hpi and GAPDH used as a
loading control. c) Indirect immunofluorescence images of TULV infected and mock infected
Vero E6 cells using the NP antisera, taken on a Zeiss LSM880 confocal microscope using x40
magnification, with the white bar representing 20 µM. Nuclei are shown in blue and TULV NP
is shown in green. d) In vitro transcribed TULV S segment vRNA, serially diluted to form a
calibration curve for quantitative RT-PCR. e) Example calibration curve generated
experimentally by quantitative RT-PCR.
Figure 2. TULV Immunofluorescent infectivity assay. a) An example of a neutral red plaque
assay well at 10-3 dilution displaying typical indistinct hantavirus plaques. b) Example images
of TULV-infected or mock-infected wells used for the immunofluorescent infectivity assay
using anti-NP antisera and the Incucyte ZOOM instrument, with (IF) and without (object mask)
analysis using masking software to count immunofluorescent units. c) Linear range describing
dilution factor of immunofluorescent assay.
Figure 3. Kinetics of TULV replication in Vero E6 cells. a) Western blot using anti-TULV
NP and anti-GAPDH antibodies of TULV-infected Vero E6 cell lysates collected at time points
spanning 1-10 dpi, with NP levels quantified using densitometry in relation to the GAPDH
loading control. b) TULV RNA genome copies per ml as quantified using one-step quantitative
RT-PCR on samples collected 1-10 dpi, and c) extended to 1-30 dpi. d) TULV infectious titres
determined by the immunofluorescence infectivity assay on samples collected 1-10 dpi, and
e) extended to 1-30 dpi. f) Laser scanning confocal images taken of TULV infected Vero E6
cells at 1.5 dpi, 7 dpi and 30 dpi using 40x magnification stained using anti-TULV NP antisera,
with the white bar representing 20 µM. Nuclei were stained with DAPI and shown in blue and
TULV NP is shown in green.
Figure 4. Examination of the induction of apoptotic markers during TULV infection of
vero E6 cells TULV infected Vero E6 cell lysates collected from 1-10 dpi and 30 dpi and
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examined by western blotting for the presence of TULV NP, pre-caspase 3 (casp-3), active
caspase 3 (casp-3C) and cleaved PARP (PARP-C) alongside a GAPDH loading control.
Figure 5. Detection of active cleaved caspase 3 in bystander cells, but not infected cells,
within TULV infected Vero E6 cultures. a) Indirect immunofluorescence of TULV-infected
Vero E6 cells at 1.5 dpi using antisera specific for TULV NP and cleaved caspase 3 (casp-
3C). Images were taken using laser scanning confocal microscopy using 40x magnification,
with casp-3C shown in red, TULV NP shown in green, and DAPI in blue. The white bar
represents 20 µM. b) Merged zoom images of four representative bystander cells with white
bar representing 10 µM. c). Quantification of the percentage of TULV-infected and bystander
cells exhibiting casp-3C staining. d). Fluorescent line scans of both bystander and TULV
infected cells of the right hand merge panel shown in panel a, taken along grey bars using Fiji
software, with the red line representing NP and green line representing casp-3C .
Figure 6. Active caspase 3 colocalises with TULV NP in the cytoplasm at later stages of
infection. a) Indirect immunofluorescence of Vero E6 cells infected with TULV at 7 dpi, or b)
30 dpi. Images taken using laser scanning confocal microscopy using 100x magnification, with
casp-3C signal in red, nucleocapsid protein (NP) in green and DAPI in blue, with the white bar
representing 20 µM. Merged images are shown on the right, with a zoomed merge in which
the white bar represents 10 µM. A fluorescent line scan was taken along the grey the bar
shown on the zoomed merged image using Fiji software, with the red line representing NP
and green line representing casp-3C.
Figure 7. Widefield deconvolution microscopy suggests TULV NP sequesters active
caspase 3 within compartments. a) Indirect immunofluorescence of Vero E6 cells
persistently infected with TULV at 30 dpi. Images taken using widefield deconvolution
microscopy using 100x magnification, with casp-3C signal in red, nucleocapsid protein (NP)
in green and DAPI in blue. Dashed boxes delineates inset, white bar represents 20 µM b)
Zoomed images of inset b shown in panel a, with individual and merged channels shown, with
white bar representing 10µM and position of three fluorescent line scans shown as grey bars,
taken using Fiji software. Green line represents NP and red line signal indicates casp-3C.
Histogram displays percentage of NP puncta or structures which display colocalisating signals
for TULV NP and casp-3C. For each time point (1.5 dpi, 7 dpi, 30 dpi) 100 puncta/structures
were counted using Fiji software. c) Fluorescent line scans taken using Fiji software of regions
of discrete casp-3C staining within inset c shown in panel a and plotted with the green line
representing NP and the red line representing casp-3C.
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Figure 8. TULV NP possesses a caspase-3 cleavage site and is cleaved during
apoptosis a) Multiple sequence alignment of TULV, SEOV, HTNV, PHV and ANDV NP
protein sequences carried out in Clustal W and analysed using Jalview software. The red box
highlights the identified caspase-3 cleavage sites b) TULV NP cell lysates examined for the
presecence of TULV NP (FL NP) and the cleavage products at 32 kDa and 16 kDa. c)
Immunoprecipitation using TULV NP antisera coprecipitates full-length and cleaved forms of
TULV NP (50 kDa) along with casp 3-C (17 kDa)
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